Inhibitors of sphingomyelinase, annexin A1 can act on extracellular vesicles secretion and intake while other agents such as ADAM10 inhibitors could directly interfere with the jap junctions connecting GBM to other cells. The gene discussed is ANXA1; the disease is glioblastoma.